BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1307 related articles for article (PubMed ID: 11041709)

  • 1. Current approach to the acute management of cryptococcal infections.
    Powderly WG
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
    AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
    [No Abstract]   [Full Text] [Related]  

  • 3. Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.
    Zeind CS; Cleveland KO; Menon M; Brown JR; Solomon DK
    Pharmacotherapy; 1996; 16(4):547-61. PubMed ID: 8840361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-associated disseminated cryptococcosis-An unusual clinical and diagnostic picture with successful cure by single dose liposomal amphotericin B treatment.
    Gupta C; Dogra P; Jain V; Kaur R; Sharma JB
    Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116217. PubMed ID: 38513558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of cryptococcal disease in patients with AIDS.
    Bozzette SA
    Curr Clin Top Infect Dis; 1993; 13():250-68. PubMed ID: 8397913
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical problems in medical mycology: problem number 41].
    Negroni R; Arechavala A; Maiolo E; Bianchi M; Santiso G; Lehmann E
    Rev Iberoam Micol; 2011; 28(1):53-5. PubMed ID: 21167296
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of cryptococcosis in patients with acquired immunodeficiency syndrome].
    Graybill JR
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():26-30. PubMed ID: 9441302
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating cryptococcal meningitis in people with HIV.
    BMJ; 2013 Apr; 346():f2203. PubMed ID: 23575571
    [No Abstract]   [Full Text] [Related]  

  • 11. Resolution of cryptococcal meningitis and associated granuloma lung with antifungal therapy: report of a case.
    Ray D; Gnanamuthu C
    Indian J Chest Dis Allied Sci; 1994; 36(3):153-8. PubMed ID: 7737703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
    Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M
    Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
    Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
    Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cryptococcus meningitis, five years of experience and literature review].
    Dorneanu O; Filip O; Miftode E; Radu I; Nicolau C; Damian I; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):100-3. PubMed ID: 18677910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
    Jaruratanasirikul S
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS.
    Chotmongkol V; Sukeepaisarncharoen W; Thavornpitak Y
    J Med Assoc Thai; 1997 Jul; 80(7):416-25. PubMed ID: 9277070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful discontinuation of antifungal secondary prophylaxis in AIDS-related cryptococcosis].
    Negroni R; Helou SH; López Daneri G; Robles AM; Arechavala AI; Bianchi MH
    Rev Argent Microbiol; 2004; 36(3):113-7. PubMed ID: 15559192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Focusing on therapy of systemic mycoses].
    Internist (Berl); 1995 Dec; 36(12 Suppl):1-12. PubMed ID: 9022383
    [No Abstract]   [Full Text] [Related]  

  • 20. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
    Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N
    Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.